Global and China Gastroesophageal Reflux Disease Therapeutics Market Size, Status and Forecast 2020-2026

Global and China Gastroesophageal Reflux Disease Therapeutics Market Size, Status and Forecast 2020-2026

Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Gastroesophageal Reflux Disease Therapeutics Market Size Growth Rate by Type: 2020 VS 2026
1.2.2 Antacids
1.2.3 H2 Receptor Blockers
1.2.4 Proton Pump Inhibitors (PPIs)
1.2.5 Pro-kinetic Agents
1.2.6 Others
1.3 Market by Application
1.3.1 Global Gastroesophageal Reflux Disease Therapeutics Market Share by Application: 2020 VS 2026
1.3.2 Hospital Pharmacy
1.3.3 Drug Stores
1.3.4 General Stores
1.3.5 Supermarkets
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Gastroesophageal Reflux Disease Therapeutics Market Perspective (2015-2026)
2.2 Global Gastroesophageal Reflux Disease Therapeutics Growth Trends by Regions
2.2.1 Gastroesophageal Reflux Disease Therapeutics Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Gastroesophageal Reflux Disease Therapeutics Historic Market Share by Regions (2015-2020)
2.2.3 Gastroesophageal Reflux Disease Therapeutics Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Gastroesophageal Reflux Disease Therapeutics Players by Market Size
3.1.1 Global Top Gastroesophageal Reflux Disease Therapeutics Players by Revenue (2015-2020)
3.1.2 Global Gastroesophageal Reflux Disease Therapeutics Revenue Market Share by Players (2015-2020)
3.2 Global Gastroesophageal Reflux Disease Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Gastroesophageal Reflux Disease Therapeutics Revenue
3.4 Global Gastroesophageal Reflux Disease Therapeutics Market Concentration Ratio
3.4.1 Global Gastroesophageal Reflux Disease Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Gastroesophageal Reflux Disease Therapeutics Revenue in 2019
3.5 Key Players Gastroesophageal Reflux Disease Therapeutics Area Served
3.6 Key Players Gastroesophageal Reflux Disease Therapeutics Product Solution and Service
3.7 Date of Enter into Gastroesophageal Reflux Disease Therapeutics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Gastroesophageal Reflux Disease Therapeutics Breakdown Data by Type (2015-2026)
4.1 Global Gastroesophageal Reflux Disease Therapeutics Historic Market Size by Type (2015-2020)
4.2 Global Gastroesophageal Reflux Disease Therapeutics Forecasted Market Size by Type (2021-2026)
5 Gastroesophageal Reflux Disease Therapeutics Breakdown Data by Application (2015-2026)
5.1 Global Gastroesophageal Reflux Disease Therapeutics Historic Market Size by Application (2015-2020)
5.2 Global Gastroesophageal Reflux Disease Therapeutics Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Gastroesophageal Reflux Disease Therapeutics Market Size (2015-2026)
6.2 North America Gastroesophageal Reflux Disease Therapeutics Market Size by Type (2015-2020)
6.3 North America Gastroesophageal Reflux Disease Therapeutics Market Size by Application (2015-2020)
6.4 North America Gastroesophageal Reflux Disease Therapeutics Market Size by Country (2015-2020)
6.4.1 United States
6.4.2 Canada
7 Europe
7.1 Europe Gastroesophageal Reflux Disease Therapeutics Market Size (2015-2026)
7.2 Europe Gastroesophageal Reflux Disease Therapeutics Market Size by Type (2015-2020)
7.3 Europe Gastroesophageal Reflux Disease Therapeutics Market Size by Application (2015-2020)
7.4 Europe Gastroesophageal Reflux Disease Therapeutics Market Size by Country (2015-2020)
7.4.1 Germany
7.4.2 France
7.4.3 U.K.
7.4.4 Italy
7.4.5 Russia
7.4.6 Nordic
7.4.7 Rest of Europe
8 China
8.1 China Gastroesophageal Reflux Disease Therapeutics Market Size (2015-2026)
8.2 China Gastroesophageal Reflux Disease Therapeutics Market Size by Type (2015-2020)
8.3 China Gastroesophageal Reflux Disease Therapeutics Market Size by Application (2015-2020)
8.4 China Gastroesophageal Reflux Disease Therapeutics Market Size by Region (2015-2020)
8.4.1 China
8.4.2 Japan
8.4.3 South Korea
8.4.4 Southeast Asia
8.4.5 India
8.4.6 Australia
8.4.7 Rest of Asia-Pacific
9 Japan
9.1 Japan Gastroesophageal Reflux Disease Therapeutics Market Size (2015-2026)
9.2 Japan Gastroesophageal Reflux Disease Therapeutics Market Size by Type (2015-2020)
9.3 Japan Gastroesophageal Reflux Disease Therapeutics Market Size by Application (2015-2020)
9.4 Japan Gastroesophageal Reflux Disease Therapeutics Market Size by Country (2015-2020)
9.4.1 Mexico
9.4.2 Brazil
10 Southeast Asia
10.1 Southeast Asia Gastroesophageal Reflux Disease Therapeutics Market Size (2015-2026)
10.2 Southeast Asia Gastroesophageal Reflux Disease Therapeutics Market Size by Type (2015-2020)
10.3 Southeast Asia Gastroesophageal Reflux Disease Therapeutics Market Size by Application (2015-2020)
10.4 Southeast Asia Gastroesophageal Reflux Disease Therapeutics Market Size by Country (2015-2020)
10.4.1 Turkey
10.4.2 Saudi Arabia
10.4.3 UAE
10.4.4 Rest of Middle East & Africa
11 Key Players Profiles
11.1 AstraZeneca
11.1.1 AstraZeneca Company Details
11.1.2 AstraZeneca Business Overview
11.1.3 AstraZeneca Gastroesophageal Reflux Disease Therapeutics Introduction
11.1.4 AstraZeneca Revenue in Gastroesophageal Reflux Disease Therapeutics Business (2015-2020))
11.1.5 AstraZeneca Recent Development
11.2 Eisai
11.2.1 Eisai Company Details
11.2.2 Eisai Business Overview
11.2.3 Eisai Gastroesophageal Reflux Disease Therapeutics Introduction
11.2.4 Eisai Revenue in Gastroesophageal Reflux Disease Therapeutics Business (2015-2020)
11.2.5 Eisai Recent Development
11.3 Takeda Pharmaceutical
11.3.1 Takeda Pharmaceutical Company Details
11.3.2 Takeda Pharmaceutical Business Overview
11.3.3 Takeda Pharmaceutical Gastroesophageal Reflux Disease Therapeutics Introduction
11.3.4 Takeda Pharmaceutical Revenue in Gastroesophageal Reflux Disease Therapeutics Business (2015-2020)
11.3.5 Takeda Pharmaceutical Recent Development
11.4 GlaxoSmithKline
11.4.1 GlaxoSmithKline Company Details
11.4.2 GlaxoSmithKline Business Overview
11.4.3 GlaxoSmithKline Gastroesophageal Reflux Disease Therapeutics Introduction
11.4.4 GlaxoSmithKline Revenue in Gastroesophageal Reflux Disease Therapeutics Business (2015-2020)
11.4.5 GlaxoSmithKline Recent Development
11.5 Johnson & Johnson
11.5.1 Johnson & Johnson Company Details
11.5.2 Johnson & Johnson Business Overview
11.5.3 Johnson & Johnson Gastroesophageal Reflux Disease Therapeutics Introduction
11.5.4 Johnson & Johnson Revenue in Gastroesophageal Reflux Disease Therapeutics Business (2015-2020)
11.5.5 Johnson & Johnson Recent Development
11.6 Daewoong Pharmaceutical
11.6.1 Daewoong Pharmaceutical Company Details
11.6.2 Daewoong Pharmaceutical Business Overview
11.6.3 Daewoong Pharmaceutical Gastroesophageal Reflux Disease Therapeutics Introduction
11.6.4 Daewoong Pharmaceutical Revenue in Gastroesophageal Reflux Disease Therapeutics Business (2015-2020)
11.6.5 Daewoong Pharmaceutical Recent Development
11.7 Ironwood Pharmaceuticals
11.7.1 Ironwood Pharmaceuticals Company Details
11.7.2 Ironwood Pharmaceuticals Business Overview
11.7.3 Ironwood Pharmaceuticals Gastroesophageal Reflux Disease Therapeutics Introduction
11.7.4 Ironwood Pharmaceuticals Revenue in Gastroesophageal Reflux Disease Therapeutics Business (2015-2020)
11.7.5 Ironwood Pharmaceuticals Recent Development
11.8 Rottapharm Madaus
11.8.1 Rottapharm Madaus Company Details
11.8.2 Rottapharm Madaus Business Overview
11.8.3 Rottapharm Madaus Gastroesophageal Reflux Disease Therapeutics Introduction
11.8.4 Rottapharm Madaus Revenue in Gastroesophageal Reflux Disease Therapeutics Business (2015-2020)
11.8.5 Rottapharm Madaus Recent Development
11.9 Peer Medical
11.9.1 Peer Medical Company Details
11.9.2 Peer Medical Business Overview
11.9.3 Peer Medical Gastroesophageal Reflux Disease Therapeutics Introduction
11.9.4 Peer Medical Revenue in Gastroesophageal Reflux Disease Therapeutics Business (2015-2020)
11.9.5 Peer Medical Recent Development
11.10 Reviva Pharmaceuticals
11.10.1 Reviva Pharmaceuticals Company Details
11.10.2 Reviva Pharmaceuticals Business Overview
11.10.3 Reviva Pharmaceuticals Gastroesophageal Reflux Disease Therapeutics Introduction
11.10.4 Reviva Pharmaceuticals Revenue in Gastroesophageal Reflux Disease Therapeutics Business (2015-2020)
11.10.5 Reviva Pharmaceuticals Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
Table 1. Global Gastroesophageal Reflux Disease Therapeutics Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 3. Key Players of Antacids
Table 4. Key Players of H2 Receptor Blockers
Table 5. Key Players of Proton Pump Inhibitors (PPIs)
Table 6. Key Players of Pro-kinetic Agents
Table 7. Key Players of Others
Table 8. Global Gastroesophageal Reflux Disease Therapeutics Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 9. Global Gastroesophageal Reflux Disease Therapeutics Market Size by Regions (US$ Million): 2020 VS 2026
Table 10. Global Gastroesophageal Reflux Disease Therapeutics Market Size by Regions (2015-2020) (US$ Million)
Table 11. Global Gastroesophageal Reflux Disease Therapeutics Market Share by Regions (2015-2020)
Table 12. Global Gastroesophageal Reflux Disease Therapeutics Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 13. Global Gastroesophageal Reflux Disease Therapeutics Market Share by Regions (2021-2026)
Table 14. Gastroesophageal Reflux Disease Therapeutics Market Market Trends
Table 15. Gastroesophageal Reflux Disease Therapeutics Market Drivers
Table 16. Gastroesophageal Reflux Disease Therapeutics Market Challenges
Table 17. Gastroesophageal Reflux Disease Therapeutics Market Restraints
Table 18. Global Gastroesophageal Reflux Disease Therapeutics Revenue by Players (2015-2020) (US$ Million)
Table 19. Global Gastroesophageal Reflux Disease Therapeutics Market Share by Players (2015-2020)
Table 20. Global Top Gastroesophageal Reflux Disease Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Gastroesophageal Reflux Disease Therapeutics as of 2019)
Table 21. Global Gastroesophageal Reflux Disease Therapeutics by Players Market Concentration Ratio (CR5 and HHI)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Gastroesophageal Reflux Disease Therapeutics Product Solution and Service
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Gastroesophageal Reflux Disease Therapeutics Market Size by Type (2015-2020) (US$ Million)
Table 26. Global Gastroesophageal Reflux Disease Therapeutics Market Size Share by Type (2015-2020)
Table 27. Global Gastroesophageal Reflux Disease Therapeutics Revenue Market Share by Type (2021-2026)
Table 28. Global Gastroesophageal Reflux Disease Therapeutics Market Size Share by Application (2015-2020)
Table 29. Global Gastroesophageal Reflux Disease Therapeutics Market Size by Application (2015-2020) (US$ Million)
Table 30. Global Gastroesophageal Reflux Disease Therapeutics Market Size Share by Application (2021-2026)
Table 31. North America Gastroesophageal Reflux Disease Therapeutics Market Size by Type (2015-2020) (US$ Million)
Table 32. North America Gastroesophageal Reflux Disease Therapeutics Market Share by Type (2015-2020)
Table 33. North America Gastroesophageal Reflux Disease Therapeutics Market Size by Application (2015-2020) (US$ Million)
Table 34. North America Gastroesophageal Reflux Disease Therapeutics Market Share by Application (2015-2020)
Table 35. North America Gastroesophageal Reflux Disease Therapeutics Market Size by Country (US$ Million) (2015-2020)
Table 36. North America Gastroesophageal Reflux Disease Therapeutics Market Share by Country (2015-2020)
Table 37. Europe Gastroesophageal Reflux Disease Therapeutics Market Size by Type (2015-2020) (US$ Million)
Table 38. Europe Gastroesophageal Reflux Disease Therapeutics Market Share by Type (2015-2020)
Table 39. Europe Gastroesophageal Reflux Disease Therapeutics Market Size by Application (2015-2020) (US$ Million)
Table 40. Europe Gastroesophageal Reflux Disease Therapeutics Market Share by Application (2015-2020)
Table 41. Europe Gastroesophageal Reflux Disease Therapeutics Market Size by Country (US$ Million) (2015-2020)
Table 42. Europe Gastroesophageal Reflux Disease Therapeutics Market Share by Country (2015-2020)
Table 43. China Gastroesophageal Reflux Disease Therapeutics Market Size by Type (2015-2020) (US$ Million)
Table 44. China Gastroesophageal Reflux Disease Therapeutics Market Share by Type (2015-2020)
Table 45. China Gastroesophageal Reflux Disease Therapeutics Market Size by Application (2015-2020) (US$ Million)
Table 46. China Gastroesophageal Reflux Disease Therapeutics Market Share by Application (2015-2020)
Table 47. China Gastroesophageal Reflux Disease Therapeutics Market Size by Region (US$ Million) (2015-2020)
Table 48. China Gastroesophageal Reflux Disease Therapeutics Market Share by Region (2015-2020)
Table 49. Japan Gastroesophageal Reflux Disease Therapeutics Market Size by Type (2015-2020) (US$ Million)
Table 50. Japan Gastroesophageal Reflux Disease Therapeutics Market Share by Type (2015-2020)
Table 51. Japan Gastroesophageal Reflux Disease Therapeutics Market Size by Application (2015-2020) (US$ Million)
Table 52. Japan Gastroesophageal Reflux Disease Therapeutics Market Share by Application (2015-2020)
Table 53. Japan Gastroesophageal Reflux Disease Therapeutics Market Size by Country (US$ Million) (2015-2020)
Table 54. Japan Gastroesophageal Reflux Disease Therapeutics Market Share by Country (2015-2020)
Table 55. Southeast Asia Gastroesophageal Reflux Disease Therapeutics Market Size by Type (2015-2020) (US$ Million)
Table 56. Southeast Asia Gastroesophageal Reflux Disease Therapeutics Market Share by Type (2015-2020)
Table 57. Southeast Asia Gastroesophageal Reflux Disease Therapeutics Market Size by Application (2015-2020) (US$ Million)
Table 58. Southeast Asia Gastroesophageal Reflux Disease Therapeutics Market Share by Application (2015-2020)
Table 59. Southeast Asia Gastroesophageal Reflux Disease Therapeutics Market Size by Country (US$ Million) (2015-2020)
Table 60. Southeast Asia Gastroesophageal Reflux Disease Therapeutics Market Share by Country (2015-2020)
Table 61. AstraZeneca Company Details
Table 62. AstraZeneca Business Overview
Table 63. AstraZeneca Product
Table 64. AstraZeneca Revenue in Gastroesophageal Reflux Disease Therapeutics Business (2015-2020) (US$ Million)
Table 65. AstraZeneca Recent Development
Table 66. Eisai Company Details
Table 67. Eisai Business Overview
Table 68. Eisai Product
Table 69. Eisai Revenue in Gastroesophageal Reflux Disease Therapeutics Business (2015-2020) (US$ Million)
Table 70. Eisai Recent Development
Table 71. Takeda Pharmaceutical Company Details
Table 72. Takeda Pharmaceutical Business Overview
Table 73. Takeda Pharmaceutical Product
Table 74. Takeda Pharmaceutical Revenue in Gastroesophageal Reflux Disease Therapeutics Business (2015-2020) (US$ Million)
Table 75. Takeda Pharmaceutical Recent Development
Table 76. GlaxoSmithKline Company Details
Table 77. GlaxoSmithKline Business Overview
Table 78. GlaxoSmithKline Product
Table 79. GlaxoSmithKline Revenue in Gastroesophageal Reflux Disease Therapeutics Business (2015-2020) (US$ Million)
Table 80. GlaxoSmithKline Recent Development
Table 81. Johnson & Johnson Company Details
Table 82. Johnson & Johnson Business Overview
Table 83. Johnson & Johnson Product
Table 84. Johnson & Johnson Revenue in Gastroesophageal Reflux Disease Therapeutics Business (2015-2020) (US$ Million)
Table 85. Johnson & Johnson Recent Development
Table 86. Daewoong Pharmaceutical Company Details
Table 87. Daewoong Pharmaceutical Business Overview
Table 88. Daewoong Pharmaceutical Product
Table 89. Daewoong Pharmaceutical Revenue in Gastroesophageal Reflux Disease Therapeutics Business (2015-2020) (US$ Million)
Table 90. Daewoong Pharmaceutical Recent Development
Table 91. Ironwood Pharmaceuticals Company Details
Table 92. Ironwood Pharmaceuticals Business Overview
Table 93. Ironwood Pharmaceuticals Product
Table 94. Ironwood Pharmaceuticals Revenue in Gastroesophageal Reflux Disease Therapeutics Business (2015-2020) (US$ Million)
Table 95. Ironwood Pharmaceuticals Recent Development
Table 96. Rottapharm Madaus Business Overview
Table 97. Rottapharm Madaus Product
Table 98. Rottapharm Madaus Company Details
Table 99. Rottapharm Madaus Revenue in Gastroesophageal Reflux Disease Therapeutics Business (2015-2020) (US$ Million)
Table 100. Rottapharm Madaus Recent Development
Table 101. Peer Medical Company Details
Table 102. Peer Medical Business Overview
Table 103. Peer Medical Product
Table 104. Peer Medical Revenue in Gastroesophageal Reflux Disease Therapeutics Business (2015-2020) (US$ Million)
Table 105. Peer Medical Recent Development
Table 106. Reviva Pharmaceuticals Company Details
Table 107. Reviva Pharmaceuticals Business Overview
Table 108. Reviva Pharmaceuticals Product
Table 109. Reviva Pharmaceuticals Revenue in Gastroesophageal Reflux Disease Therapeutics Business (2015-2020) (US$ Million)
Table 110. Reviva Pharmaceuticals Recent Development
Table 111. Research Programs/Design for This Report
Table 112. Key Data Information from Secondary Sources
Table 113. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Gastroesophageal Reflux Disease Therapeutics Market Share by Type: 2020 VS 2026
Figure 2. Antacids Features
Figure 3. H2 Receptor Blockers Features
Figure 4. Proton Pump Inhibitors (PPIs) Features
Figure 5. Pro-kinetic Agents Features
Figure 6. Others Features
Figure 7. Global Gastroesophageal Reflux Disease Therapeutics Market Share by Application: 2020 VS 2026
Figure 8. Hospital Pharmacy Case Studies
Figure 9. Drug Stores Case Studies
Figure 10. General Stores Case Studies
Figure 11. Supermarkets Case Studies
Figure 12. Gastroesophageal Reflux Disease Therapeutics Report Years Considered
Figure 13. Global Gastroesophageal Reflux Disease Therapeutics Market Size (US$ Million), YoY Growth 2015-2026
Figure 14. Global Gastroesophageal Reflux Disease Therapeutics Market Share by Regions: 2020 VS 2026
Figure 15. Global Gastroesophageal Reflux Disease Therapeutics Market Share by Regions (2021-2026)
Figure 16. Global Gastroesophageal Reflux Disease Therapeutics Market Share by Players in 2019
Figure 17. Global Top Gastroesophageal Reflux Disease Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Gastroesophageal Reflux Disease Therapeutics as of 2019
Figure 18. The Top 10 and 5 Players Market Share by Gastroesophageal Reflux Disease Therapeutics Revenue in 2019
Figure 19. North America Gastroesophageal Reflux Disease Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 20. United States Gastroesophageal Reflux Disease Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 21. Canada Gastroesophageal Reflux Disease Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 22. Europe Gastroesophageal Reflux Disease Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 23. Germany Gastroesophageal Reflux Disease Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 24. France Gastroesophageal Reflux Disease Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 25. U.K. Gastroesophageal Reflux Disease Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 26. Italy Gastroesophageal Reflux Disease Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 27. Russia Gastroesophageal Reflux Disease Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 28. Nordic Gastroesophageal Reflux Disease Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 29. Rest of Europe Gastroesophageal Reflux Disease Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 30. Asia-Pacific Gastroesophageal Reflux Disease Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 31. China Gastroesophageal Reflux Disease Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 32. Japan Gastroesophageal Reflux Disease Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 33. South Korea Gastroesophageal Reflux Disease Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 34. Southeast Asia Gastroesophageal Reflux Disease Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 35. India Gastroesophageal Reflux Disease Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 36. Australia Gastroesophageal Reflux Disease Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 37. Rest of Asia-Pacific Gastroesophageal Reflux Disease Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 38. Latin America Gastroesophageal Reflux Disease Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 39. Mexico Gastroesophageal Reflux Disease Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 40. Brazil Gastroesophageal Reflux Disease Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 41. Middle East & Africa Gastroesophageal Reflux Disease Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 42. Turkey Gastroesophageal Reflux Disease Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 43. Saudi Arabia Gastroesophageal Reflux Disease Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 44. UAE Gastroesophageal Reflux Disease Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 45. Rest of Middle East & Africa Gastroesophageal Reflux Disease Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 46. AstraZeneca Revenue Growth Rate in Gastroesophageal Reflux Disease Therapeutics Business (2015-2020)
Figure 47. Eisai Revenue Growth Rate in Gastroesophageal Reflux Disease Therapeutics Business (2015-2020)
Figure 48. Takeda Pharmaceutical Revenue Growth Rate in Gastroesophageal Reflux Disease Therapeutics Business (2015-2020)
Figure 49. GlaxoSmithKline Revenue Growth Rate in Gastroesophageal Reflux Disease Therapeutics Business (2015-2020)
Figure 50. Johnson & Johnson Revenue Growth Rate in Gastroesophageal Reflux Disease Therapeutics Business (2015-2020)
Figure 51. Daewoong Pharmaceutical Revenue Growth Rate in Gastroesophageal Reflux Disease Therapeutics Business (2015-2020)
Figure 52. Ironwood Pharmaceuticals Revenue Growth Rate in Gastroesophageal Reflux Disease Therapeutics Business (2015-2020)
Figure 53. Rottapharm Madaus Revenue Growth Rate in Gastroesophageal Reflux Disease Therapeutics Business (2015-2020)
Figure 54. Peer Medical Revenue Growth Rate in Gastroesophageal Reflux Disease Therapeutics Business (2015-2020)
Figure 55. Reviva Pharmaceuticals Revenue Growth Rate in Gastroesophageal Reflux Disease Therapeutics Business (2015-2020)
Figure 56. Bottom-up and Top-down Approaches for This Report
Figure 57. Data Triangulation
Figure 58. Key Executives Interviewed

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Nuclear Medicine Cyclotron Systems Market Report, History and Forecast 2018-2029

Published: 11-Jan-2024        Price: US 3350 Onwards        Pages: 118

The global Nuclear Medicine Cyclotron Systems market was valued at US$ 220.85 million in 2022 and will reach US$ 283.75 million by the end of 2029, growing at a CAGR of 4.38% during 2023-2029. Asia-Pacific market for Nuclear Medicine Cyclotron Systems was valued at $ 61.16 million in 2022 and will reach $ 104.22 million by 2029, at a CAGR of 5.84% during the forecast period of 2023 through 2029. Report Scope This report aims to provide a comprehensive presentation of the glo......

Global Non-imaging Diagnostic Catheter Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 95

The global Non-imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......

Global Imaging Diagnostic Catheter Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 90

The global Imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estimated......

Global PCR Equipment Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 77

The global PCR Equipment market was valued at US$ 806 million in 2023 and is anticipated to reach US$ 1230.7 million by 2030, witnessing a CAGR of 6.7% during The forecast period 2024-2030. PCR (Polymerase Chain Reaction) equipment is widely used in molecular biology and genetics research for amplifying DNA and RNA sequences. The market for PCR equipment is influenced by several key drivers. Here are some of The significant market drivers: Advancements in Research and Diagnost......

Global Disposable Sterile Syringes and Needles Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 109

The global Disposable Sterile Syringes and Needles market was valued at US$ 404.4 million in 2023 and is anticipated to reach US$ 539.1 million by 2030, witnessing a CAGR of 2.1% during The forecast period 2024-2030. North American market for Disposable Sterile Syringes and Needles is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Disposable Sterile Syringes and N......

Global Orthopaedic Power Tools Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106

The global Orthopaedic Power Tools market was valued at US$ 463.3 million in 2023 and is anticipated to reach US$ 746.5 million by 2030, witnessing a CAGR of 7.3% during The forecast period 2024-2030. North American market for Orthopaedic Power Tools is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Orthopaedic Power Tools is estimated to increase from $ million i......

Global Cerebrospinal Fluid Management Devices Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86

The global Cerebrospinal Fluid Management Devices market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Cerebrospinal Fluid Management Devices is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Cerebrospinal Fluid Management Devices is estimate......

Global CAD & CAM Milling Burs Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 79

The global CAD & CAM Milling Burs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ ......

Global Artificial Teeth Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 98

The global Artificial Teeth market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, a......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs